Investing.com - Laboratory America reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Laboratory America announced earnings per share of $6.82 on revenue of $4.06B. Analysts polled by Investing.com anticipated EPS of $4.92 on revenue of $3.65B.
Laboratory America shares are up 34% from the beginning of the year and are trading at $289.00 , down-from-52-week-high.They are outperforming the S&P 500 which is up 21.18% from the start of the year.
Laboratory America shares gained 3.03% in pre-market trade the report.
Laboratory America follows other major Healthcare sector earnings this month
Laboratory America's report follows an earnings beat by Merck&Co on Thursday, who reported EPS of $1.75 on revenue of $13.15B, compared to forecasts EPS of $1.54 on revenue of $12.26B.
Hoya Corp had beat expectations on Thursday with third quarter EPS of $1.02 on revenue of $1.43B, compared to forecast for EPS of $0.9772 on revenue of $1.42B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar